JSGTX
Price
$22.93
Change
-$1.41 (-5.79%)
Updated
Apr 4 closing price
Net Assets
1.39B
RGACX
Price
$60.87
Change
-$3.73 (-5.77%)
Updated
Apr 4 closing price
Net Assets
248.76B
Ad is loading...

JSGTX vs RGACX

Header iconJSGTX vs RGACX Comparison
Open Charts JSGTX vs RGACXBanner chart's image
JHancock U.S. Growth R6
Price$22.93
Change-$1.41 (-5.79%)
VolumeN/A
Net Assets1.39B
American Funds Growth Fund of Amer R3
Price$60.87
Change-$3.73 (-5.77%)
VolumeN/A
Net Assets248.76B
JSGTX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSGTX vs. RGACX commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSGTX is a Hold and RGACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 249B vs. JSGTX (1.39B). RGACX pays higher dividends than JSGTX: RGACX (0.09) vs JSGTX (0.00). JSGTX was incepted earlier than RGACX: JSGTX (10 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than JSGTX (0.63). JSGTX is a more actively managed with annual turnover of: 69.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than JSGTX: RGACX (250) vs JSGTX (1000000). RGACX annual gain was more profitable for investors over the last year : -10.20 vs. JSGTX (-11.16). RGACX return over 5 years is better than : 49.81 vs. JSGTX (46.69).
JSGTXRGACXJSGTX / RGACX
Total Expense Ratio0.630.9467%
Annual Report Gross Expense Ratio0.630.9467%
Fund Existence10 years23 years-
Gain YTD-16.860-15.447109%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B249B1%
Annual Yield % from dividends0.000.09-
Returns for 1 year-11.16-10.20109%
Returns for 3 years-2.21-5.4640%
Returns for 5 years46.6949.8194%
Returns for 10 years41.2639.96103%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRSN0.990.04
+4.49%
NeuroSense Therapeutics Ltd
XTKG1.11-0.01
-0.89%
X3 Holdings Co Ltd
RMD205.17-8.18
-3.83%
ResMed
AVNT30.43-2.07
-6.37%
Avient Corp
BCSF15.12-1.11
-6.84%
Bain Capital Specialty Finance